- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Growth Potential Companies
Global Pharmaceuticals & Biotech High Growth Potential Companies
Results
511
Companies with a Future performance score of at least 3, ordered by Future performance score.
511 companies
Alnylam Pharmaceuticals
Market Cap: US$31.1b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$230.93
7D
2.9%
1Y
57.4%
Travere Therapeutics
Market Cap: US$1.3b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$14.91
7D
5.4%
1Y
142.4%
Ascendis Pharma
Market Cap: US$9.3b
A biopharmaceutical company, focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
ASND
US$153.92
7D
12.0%
1Y
8.8%
Axsome Therapeutics
Market Cap: US$5.0b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$103.83
7D
6.4%
1Y
50.9%
Ascelia Pharma
Market Cap: SEK 289.3m
A biotech company, focuses on orphan oncology treatments in Sweden.
ACE
SEK 3.01
7D
12.5%
1Y
-77.0%
Zevra Therapeutics
Market Cap: US$376.6m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$6.96
7D
1.6%
1Y
50.0%
AVITA Medical
Market Cap: US$236.6m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$9.23
7D
20.3%
1Y
-4.8%
Pharma Mar
Market Cap: €1.3b
A biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.
PHM
€76.35
7D
1.4%
1Y
187.7%
TG Therapeutics
Market Cap: US$5.6b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$39.03
7D
9.9%
1Y
178.8%
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥11.6b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥16.65
7D
1.1%
1Y
23.3%
Jianmin Pharmaceutical GroupLtd
Market Cap: CN¥7.2b
Manufactures and sells medicines in China.
600976
CN¥45.00
7D
-4.4%
1Y
-17.2%
Guizhou Sanli PharmaceuticalLtd
Market Cap: CN¥5.0b
GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products.
603439
CN¥12.39
7D
1.0%
1Y
-14.6%
Camurus
Market Cap: SEK 33.4b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally.
CAMX
SEK 570.00
7D
6.1%
1Y
15.9%
Arcutis Biotherapeutics
Market Cap: US$1.5b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$13.19
7D
-0.8%
1Y
30.6%
Elicera Therapeutics
Market Cap: SEK 162.6m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 3.35
7D
11.7%
1Y
180.3%
Corline Biomedical
Market Cap: SEK 232.2m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.
CLBIO
SEK 9.48
7D
3.3%
1Y
-17.6%
Oscotec
Market Cap: ₩1.3t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩32,550.00
7D
14.0%
1Y
14.2%
PharmaResearch
Market Cap: ₩3.7t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩359,500.00
7D
12.0%
1Y
180.9%
Chongqing Taiji Industry(Group)Ltd
Market Cap: CN¥12.4b
Develops, produces, and sells traditional Chinese and modern medicine products in China and internationally.
600129
CN¥22.33
7D
5.3%
1Y
-32.6%
Devyser Diagnostics
Market Cap: SEK 1.5b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 91.50
7D
0.7%
1Y
-11.6%
Xbrane Biopharma
Market Cap: SEK 310.4m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 0.20
7D
3.1%
1Y
-40.5%
Bonesupport Holding
Market Cap: SEK 21.0b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 318.80
7D
2.4%
1Y
33.8%
ALTEOGEN
Market Cap: ₩20.3t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩366,500.00
7D
5.5%
1Y
127.9%
Blue Jet Healthcare
Market Cap: ₹127.7b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹747.35
7D
19.4%
1Y
91.5%
RemeGen
Market Cap: HK$24.0b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.
9995
HK$34.90
7D
35.8%
1Y
28.8%
PharmaEssentia
Market Cap: NT$163.2b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$490.00
7D
10.0%
1Y
59.6%
Acrux
Market Cap: AU$9.0m
Engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.
ACR
AU$0.022
7D
-12.0%
1Y
-64.5%
Sernova Biotherapeutics
Market Cap: CA$55.8m
Operates as a clinical-stage biotechnology company in Canada.
SVA
CA$0.18
7D
2.9%
1Y
-61.3%
BioArctic
Market Cap: SEK 15.4b
Develops biological drugs for patients with disorders of the central nervous system in Sweden.
BIOA B
SEK 174.00
7D
2.1%
1Y
-14.6%
Botanix Pharmaceuticals
Market Cap: AU$687.3m
Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.
BOT
AU$0.39
7D
10.0%
1Y
75.0%
Beijing Wantai Biological Pharmacy Enterprise
Market Cap: CN¥86.4b
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
CN¥71.00
7D
7.4%
1Y
1.2%
Jiangsu Sinopep-Allsino Biopharmaceutical
Market Cap: CN¥10.8b
A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
688076
CN¥48.40
7D
1.0%
1Y
-6.4%
Akeso
Market Cap: HK$78.7b
A biopharmaceutical company, researches, develops, manufactures, and commercializes antibody drugs.
9926
HK$83.70
7D
17.6%
1Y
79.0%
Neuland Laboratories
Market Cap: ₹162.4b
Manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹12,742.10
7D
16.4%
1Y
69.4%
Evolus
Market Cap: US$653.0m
A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
EOLS
US$10.23
7D
9.3%
1Y
-15.1%
Innate Pharma
Market Cap: €149.2m
Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.
IPH
€1.78
7D
4.2%
1Y
-19.1%